Hong Kong IPOs lure mainland China insurers seeking higher returns
Beijing’s emphasis on patient capital and market stability spurs mainland China’s insurers to channel funds into Hong Kong listings
Ping An Insurance (Group), Taikang Life Insurance, New China Life Insurance, Dajia Life Insurance and China Post Life Insurance were among the key players that invested more than US$250 million across about 11 IPOs so far this year, according to UBS data.
Their investment accelerated, reaching about 75 per cent of the US$333 million committed for the whole of last year.
“We started to see more active participation of mainland insurers in 2026,” said John Lee Chen-kwok, vice-chairman and co-head of Asia coverage at UBS in Hong Kong. “They are overall driving up equity investment given the very low rate environment in mainland China.”
Chan said mainland insurers’ interest in Hong Kong IPOs was driven by regulatory changes, their pursuit of higher returns and strategic alignment. “The Chinese government has been actively pushing insurers to become ‘patient capital’ as they can invest [with a long-term outlook], which provides a stable funding source for the market,” he said.